Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses.

MLA

Sahay, Bikash, et al. “Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses.” Viruses (1999-4915), vol. 11, no. 2, Feb. 2019, p. 136. EBSCOhost, https://doi.org/10.3390/v11020136.

APA

Sahay, B., Aranyos, A. M., Mishra, M., McAvoy, A. C., Martin, M. M., Pu, R., Shiomitsu, S., Shiomitsu, K., Dark, M. J., Sanou, M. P., Roff, S. R., Rathore, M. H., & Yamamoto, J. K. (2019). Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses. Viruses (1999-4915), 11(2), 136. https://doi.org/10.3390/v11020136

Chicago

Sahay, Bikash, Alek M. Aranyos, Meerambika Mishra, Andrew C. McAvoy, Marcus M. Martin, Riuyu Pu, Sayaka Shiomitsu, et al. 2019. “Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses.” Viruses (1999-4915) 11 (2): 136. doi:10.3390/v11020136.